|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 298.71 USD | +0.33% |
|
+1.76% | +20.93% |
| 04-09 | UBS Adjusts Price Target on Air Products and Chemicals to $307 From $285, Maintains Neutral Rating | MT |
| 03-31 | Air Liquide, Helium and the Middle East Conflict |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.66 | 5.69 | 5.6 | 4.97 | -1.26 | |||||
Return on Total Capital | 6.83 | 6.91 | 6.78 | 5.88 | -1.46 | |||||
Return On Equity % | 15.41 | 16.22 | 15.88 | 22.58 | -1.92 | |||||
Return on Common Equity | 15.84 | 16.82 | 16.7 | 24.51 | -2.41 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.39 | 26.46 | 29.9 | 32.49 | 31.41 | |||||
SG&A Margin | 7.21 | 6.7 | 8.28 | 8.62 | 7.89 | |||||
EBITDA Margin % | 35.61 | 29.9 | 31.83 | 35.52 | 6.24 | |||||
EBITA Margin % | 23.17 | 19.64 | 21.31 | 23.79 | -6.44 | |||||
EBIT Margin % | 22.81 | 19.36 | 21.05 | 23.53 | -6.75 | |||||
Income From Continuing Operations Margin % | 19.81 | 17.75 | 18.5 | 32.03 | -2.88 | |||||
Net Income Margin % | 20.33 | 17.77 | 18.26 | 31.64 | -3.28 | |||||
Net Avail. For Common Margin % | 19.65 | 17.67 | 18.2 | 31.75 | -3.21 | |||||
Normalized Net Income Margin | 14.96 | 13.87 | 15.22 | 16.79 | -2.48 | |||||
Levered Free Cash Flow Margin | 3.85 | 0.95 | -14.64 | -27.58 | -54.79 | |||||
Unlevered Free Cash Flow Margin | 4.71 | 1.58 | -13.76 | -26.35 | -53.82 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.4 | 0.47 | 0.43 | 0.34 | 0.3 | |||||
Fixed Assets Turnover | 0.79 | 0.89 | 0.76 | 0.56 | 0.47 | |||||
Receivables Turnover (Average Receivables) | 6.72 | 7.06 | 6.47 | 6.17 | 5.91 | |||||
Inventory Turnover (Average Inventory) | 16.74 | 19.29 | 15.15 | 11.52 | 10.7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.99 | 1.81 | 1.33 | 1.52 | 1.38 | |||||
Quick Ratio | 2.67 | 1.52 | 1.06 | 1.23 | 1 | |||||
Operating Cash Flow to Current Liabilities | 1.19 | 0.93 | 0.82 | 0.87 | 0.77 | |||||
Days Sales Outstanding (Average Receivables) | 54.32 | 51.68 | 56.41 | 59.36 | 61.79 | |||||
Days Outstanding Inventory (Average Inventory) | 21.81 | 18.92 | 24.09 | 31.76 | 34.1 | |||||
Average Days Payable Outstanding | 32.36 | 36.07 | 47.48 | 58.87 | 63.77 | |||||
Cash Conversion Cycle (Average Days) | 43.76 | 34.54 | 33.02 | 32.26 | 32.11 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 58.57 | 61.44 | 71 | 80.58 | 106.23 | |||||
Total Debt / Total Capital | 36.94 | 38.06 | 41.52 | 44.62 | 51.51 | |||||
LT Debt/Equity | 54.52 | 56.7 | 64.81 | 76.32 | 101.37 | |||||
Long-Term Debt / Total Capital | 34.38 | 35.12 | 37.9 | 42.26 | 49.15 | |||||
Total Liabilities / Total Assets | 47.55 | 49.61 | 51.07 | 52.81 | 57.74 | |||||
EBIT / Interest Expense | 16.6 | 19.21 | 14.94 | 11.95 | -4.35 | |||||
EBITDA / Interest Expense | 26.55 | 30.48 | 23.22 | 18.56 | 4.68 | |||||
(EBITDA - Capex) / Interest Expense | 9.17 | 7.62 | -2.85 | -9.97 | -32.87 | |||||
Total Debt / EBITDA | 2.19 | 2.16 | 2.7 | 3.4 | 21.05 | |||||
Net Debt / EBITDA | 0.65 | 1.3 | 2.22 | 2.73 | 18.91 | |||||
Total Debt / (EBITDA - Capex) | 6.34 | 8.63 | -21.99 | -6.33 | -3 | |||||
Net Debt / (EBITDA - Capex) | 1.87 | 5.21 | -18.11 | -5.08 | -2.69 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 16.56 | 23.01 | -0.78 | -3.96 | -0.52 | |||||
Gross Profit, 1 Yr. Growth % | 4.63 | 7.12 | 12.11 | 4.38 | -3.83 | |||||
EBITDA, 1 Yr. Growth % | 7.09 | 3.29 | 5.64 | 13.33 | -82.52 | |||||
EBITA, 1 Yr. Growth % | 4.82 | 4.28 | 7.66 | 16.69 | -126.93 | |||||
EBIT, 1 Yr. Growth % | 4.77 | 4.42 | 7.9 | 16.95 | -128.54 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 5.1 | 10.24 | 3.43 | 66.28 | -108.94 | |||||
Net Income, 1 Yr. Growth % | 11.26 | 7.48 | 1.95 | 66.43 | -110.31 | |||||
Normalized Net Income, 1 Yr. Growth % | 6.29 | 14.07 | 8.86 | 14.04 | -114.72 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 6.67 | 10.53 | 2.18 | 67.38 | -110.09 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.77 | 17.29 | 0.61 | 0.98 | 6.64 | |||||
Inventory, 1 Yr. Growth % | 12.13 | 13.28 | 26.76 | 17.52 | 1.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11.99 | 7.48 | 24.17 | 32.38 | 7.63 | |||||
Total Assets, 1 Yr. Growth % | 6.72 | 1.24 | 17.69 | 23.66 | 3.75 | |||||
Tangible Book Value, 1 Yr. Growth % | 13.53 | -1.92 | 9.55 | 20.61 | -12.97 | |||||
Common Equity, 1 Yr. Growth % | 12.09 | -2.92 | 8.89 | 19.03 | -11.81 | |||||
Cash From Operations, 1 Yr. Growth % | 2.36 | -3.34 | -0.74 | 13.74 | -10.69 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.79 | 18.76 | 58.09 | 46.91 | 3.32 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 389.95 | -69.56 | -1.62K | 68.84 | 97.63 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 225.35 | -58.66 | -962.05 | 70.9 | 103.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.74 | 8.9 | 8.02 | 2.77 | 1.13 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.58 | 19.74 | 10.48 | -2.38 | -2.26 | |||||
Gross Profit, 2 Yr. CAGR % | 3.23 | 5.86 | 9.58 | 8.17 | 0.19 | |||||
EBITDA, 2 Yr. CAGR % | 6.08 | 5.15 | 4.5 | 7.4 | -55.49 | |||||
EBITA, 2 Yr. CAGR % | 3.87 | 4.51 | 6.02 | 8.99 | -43.96 | |||||
EBIT, 2 Yr. CAGR % | 3.84 | 4.56 | 6.21 | 9.19 | -42.24 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 6.3 | 7.64 | 6.78 | 31.14 | -61.45 | |||||
Net Income, 2 Yr. CAGR % | 9.21 | 9.35 | 4.68 | 30.26 | -58.59 | |||||
Normalized Net Income, 2 Yr. CAGR % | 5.09 | 10.11 | 11.43 | 8.83 | -59.03 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.17 | 8.58 | 6.27 | 30.78 | -58.9 | |||||
Accounts Receivable, 2 Yr. CAGR % | 8.14 | 17.03 | 8.63 | 0.8 | 3.77 | |||||
Inventory, 2 Yr. CAGR % | 8.12 | 12.71 | 19.83 | 22.05 | 9.15 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 15.63 | 9.71 | 15.53 | 28.21 | 19.36 | |||||
Total Assets, 2 Yr. CAGR % | 19.08 | 3.94 | 9.16 | 20.64 | 13.27 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11.4 | 5.53 | 3.66 | 14.94 | 2.45 | |||||
Common Equity, 2 Yr. CAGR % | 10.68 | 4.31 | 2.82 | 13.85 | 2.46 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.08 | -0.53 | -2.05 | 6.25 | 0.78 | |||||
Capital Expenditures, 2 Yr. CAGR % | 11.29 | 8 | 37.02 | 52.4 | 23.2 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 58.32 | 21.43 | 115.81 | 556.85 | 82.7 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 41.1 | 15.62 | 89.13 | 350.15 | 86.38 | |||||
Dividend Per Share, 2 Yr. CAGR % | 12.92 | 10.81 | 8.46 | 5.36 | 1.95 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.95 | 12.5 | 12.47 | 5.44 | -1.77 | |||||
Gross Profit, 3 Yr. CAGR % | 4.6 | 4.51 | 7.91 | 7.82 | 4.02 | |||||
EBITDA, 3 Yr. CAGR % | 8.27 | 5.14 | 5.31 | 5.38 | -41.36 | |||||
EBITA, 3 Yr. CAGR % | 6.95 | 4 | 5.55 | 6.42 | -31.61 | |||||
EBIT, 3 Yr. CAGR % | 6.94 | 4.03 | 5.66 | 6.59 | -30.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.11 | 7.6 | 6.22 | 23.77 | -46.44 | |||||
Net Income, 3 Yr. CAGR % | 11.91 | 8.63 | 6.83 | 22.18 | -44.08 | |||||
Normalized Net Income, 3 Yr. CAGR % | 8.03 | 8.01 | 9.69 | 9.58 | -44.14 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.44 | 8.28 | 6.4 | 23.65 | -44.32 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.33 | 11.1 | 11.28 | 6.02 | 2.71 | |||||
Inventory, 3 Yr. CAGR % | 4.64 | 9.81 | 17.21 | 19.06 | 14.73 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.67 | 12.85 | 14.33 | 20.89 | 20.95 | |||||
Total Assets, 3 Yr. CAGR % | 11.88 | 12.81 | 8.34 | 13.79 | 14.72 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.23 | 6.77 | 6.85 | 9.02 | 4.76 | |||||
Common Equity, 3 Yr. CAGR % | 7.64 | 5.94 | 5.82 | 7.96 | 4.56 | |||||
Cash From Operations, 3 Yr. CAGR % | 9.66 | 2.84 | -0.6 | 2.95 | 0.27 | |||||
Capital Expenditures, 3 Yr. CAGR % | 16.25 | 13.72 | 22.63 | 40.24 | 33.88 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -14.26 | -8.62 | 182.14 | 103.5 | 340.15 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -11.95 | -6.28 | 125.87 | 87.38 | 245.31 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.18 | 11.57 | 9.87 | 6.53 | 3.93 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.59 | 9.17 | 7.13 | 6.29 | 6.33 | |||||
Gross Profit, 5 Yr. CAGR % | 6.16 | 6.64 | 6.57 | 5.96 | 4.75 | |||||
EBITDA, 5 Yr. CAGR % | 8.35 | 6.97 | 6.73 | 5.65 | -26.2 | |||||
EBITA, 5 Yr. CAGR % | 7.98 | 5.96 | 6.55 | 5.37 | -19.43 | |||||
EBIT, 5 Yr. CAGR % | 7.94 | 5.91 | 6.62 | 5.45 | -18.42 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.75 | 14.3 | 9.35 | 16.46 | -29.19 | |||||
Net Income, 5 Yr. CAGR % | 27.17 | -5.54 | 8.96 | 16.81 | -26.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.05 | 10.54 | 9.38 | 7.76 | -27.1 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.59 | 14.33 | 9.34 | 16.77 | -27.27 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.96 | 7.5 | 7.24 | 6.86 | 8.21 | |||||
Inventory, 5 Yr. CAGR % | 12.22 | 8.92 | 10.47 | 14.55 | 13.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.84 | 11.97 | 13.2 | 18.76 | 16.32 | |||||
Total Assets, 5 Yr. CAGR % | 8.3 | 8.05 | 10.78 | 15.88 | 10.28 | |||||
Tangible Book Value, 5 Yr. CAGR % | 15.86 | 5.88 | 6.37 | 9.97 | 5.07 | |||||
Common Equity, 5 Yr. CAGR % | 13.85 | 5.44 | 5.68 | 9.04 | 4.46 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.66 | 15.64 | 4.82 | 4.19 | -0.05 | |||||
Capital Expenditures, 5 Yr. CAGR % | 22.11 | 23 | 24.15 | 27.85 | 22.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -12.44 | -41.01 | 23.92 | 83.9 | 140.41 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -10.46 | -35.27 | 19.46 | 67.16 | 112.24 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.49 | 11.38 | 10.08 | 9.04 | 6.63 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















